Prescription Drug Patches Gaining Ground, Tackling New Therapies

Greystone Associates Publishes New Report Analyzing Technology and Market Factors

(Amherst, NH) – Created as an alternate route of drug administration to improve patient compliance and reduce drug side effects, prescription skin patches are rapidly becoming an important healthcare product category. While quietly gaining market share for the treatment of chronic conditions such as angina, hypertension and HRT, the technology is set to make further inroads as transdermal patches for a host of new conditions wind their way through the development and clinical trial process.

Growth in demand for prescription drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Technology has also played a major role in prescription patch growth. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. “The number of drug therapies being developed in patch form is expanding,” explains George Perros, Greystone Managing Director. “At the same time, improvements in patch esthetics and the success of existing prescription patches have increased consumer market acceptance.”

These findings are contained in a new and comprehensive report. Prescription Skin Patches: Products, Players and Emerging Therapies contains detailed information on more than forty approved and probable future patch products in more than a dozen market categories. Assessments of patch technology, patch company profiles, and detailed information on product development activities, technology factors, and marketing strategies help define and quantify the growing impact of skin patches for industry participants.

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology assessment.

Source: Greystone Associates

http://www.greystoneassociates.org/News_Skin_Patch.htm